Skip to main content
. 2000 Nov;38(11):3915–3918. doi: 10.1128/jcm.38.11.3915-3918.2000

TABLE 4.

Seroprevalence of IgG and IgM anti-HEV in other liver disease controlsa

Liver disease Patients
No. (%) of patients with seroprevalence for:
No. Age (yr)b IgG anti-HEV IgM anti-HEV
Acute
 Hepatitis A 26 30 ± 11 1 (3.8) 3 (11.5)
 Hepatitis B 27 35 ± 15 0 (0) 0 (0)
 Hepatitis C 27 49 ± 17 3 (11.1) 0 (0)
 Hepatitis D 34 43 ± 18 5 (14.7) 0 (0)
Chronic
 Chronic hepatitis B with acute exacerbation 36 46 ± 16 5 (14.3) 0 (0)
 Autoimmune hepatitis 6 42 ± 21 1 (16.7) 0 (0)
 Primary biliary cirrhosis 5 63 ± 10 0 (0) 0 (0)
a

All serum samples were negative for HEV RNA. 

b

Mean ± SD. 

HHS Vulnerability Disclosure